MedSpaRadar™
Free alerts

Arkansas med spa & injectable regulations

What’s changing for med spas and injectors in Arkansas — GLP-1 compounding, scope-of-practice, and enforcement — plus the federal FDA and Federal Register actions that apply in Arkansas. MedSpaRadar monitors it all and tells you, in plain language, what changed and what to do.

Opening a med spa in Arkansas? Start with who may own one, the medical director rules, and who may inject in Arkansas →

Latest Arkansas changes

No Arkansas-specific changes have crossed our radar yet — we’re monitoring the Arkansas legislature daily. The Arkansas legislature has adjourned sine die (2026 1st Special Session). No further session is listed yet. The federal changes below apply to every Arkansas practice today.

Federal changes that apply in Arkansas

FDA and Federal Register actions are nationwide — they govern Arkansas practices too.

See the full regulatory feed →

What we monitor in Arkansas

  • Arkansas legislature — bills on injectables, GLP-1s & scope of practice
  • U.S. FDA — enforcement, warning letters, recalls, shortages
  • Federal Register — new rules on compounding & aesthetics

Arkansas med spa questions, answered from statute

The same verified record, asked the way operators actually ask it — who may own one, who may inject, what the supervising physician has to do. 21 questions have a cited Arkansas answer today.

Browse the 21 Arkansas questions →

Arkansas med-spa compliance rules

37 rules across 7 topics — physician delegation, the good-faith exam, ownership & corporate practice of medicine, RN/NP scope, med-spa registration, advertising, and enforcement — each linked to its primary source. Reference and monitoring, not legal advice.

Physician supervision & delegation9 cited rules

Arkansas says the cosmetic laser is the practice of medicine, and writes the delegation protocol around it. 17 CAR § 140-1601 finds that using medical lasers on human beings, for therapeutic or cosmetic purposes, constitutes the practice of medicine, and lets a physician delegate a minor procedure only on a protocol.

Good-faith examination5 cited rules

Within that laser rule, before a delegated minor procedure the physician must PERSONALLY diagnose the condition of the patient and prescribe the treatment and procedure to be performed.

Ownership & corporate practice of medicine4 cited rules

The board treats it as an ethical violation for a physician to fail to disclose to a patient that the physician holds an ownership interest in a facility or service, outside the physician’s own practice, to which the physician refers that patient.

RN / NP scope for injectables5 cited rules

Delegated administration of drugs covers only drugs that do not require substantial, specialized judgment and skill, and is permissible only within the physical boundaries of the delegating physician’s offices.

Disciplinary landscape4 cited rules

Arkansas ties the laser protocol straight to the disciplinary power. a physician who does not comply with it when performing minor procedures is considered to be exhibiting gross negligence and faces a disciplinary hearing before the board under the Medical Practices Act. Failing to comply with the reporting section is separately cause for revocation, suspension, probation or a monetary fine, determined after formal charges and notice. Aiding or abetting an unlicensed person to practice medicine is itself a ground on which the board may act.

  • (C) Aiding or abetting an unlicensed person to practice medicine;

    Ark. Code Ann. § 17-95-409(a)(2)(C) (Unprofessional conduct — grounds for revocation or suspension)

  • (c) A physician who does not comply with the above-stated protocol when performing minor procedures will be considered as exhibiting gross negligence, subjecting the physician to a disciplinary hearing before the board pursuant to the Arkansas Medical Practices Act, Arkansas Code § 17-95-201 et seq., Arkansas Code § 17-95-301 et seq., and Arkansas Code § 17-95-401 et seq., and the rules of the board.

    17 CAR § 140-1601(c) (Laser surgery guidelines — enforcement)

  • (b) Should a physician fail to comply with the terms of Arkansas Code § 17-95-103 and this section, then the same shall be cause for revocation, suspension, probation, or monetary fine as may be determined by the board after the bringing of formal charges and notifying the physician as required by the Arkansas Medical Practices Act

    17 CAR § 140-1701(b) (Reporting generally — consequence)

  • The Arkansas State Medical Board may revoke an existing license, impose penalties, or refuse to issue a license in the event the holder or applicant has committed any of the acts or offenses defined in the section to be unprofessional conduct; the words unprofessional conduct mean, among other things, conviction of a listed felony, resorting to fraud, misrepresentation, or deception in applying for or securing a license to practice medicine, and aiding or abetting an unlicensed person to practice medicine.

    Ark. Code Ann. § 17-95-409(a)(1)–(2)(C)

Med-spa registration & licensing8 cited rules

⚠️ Arkansas reaches the room through its office-based surgery rule. Each office-based surgery must be within the physician’s scope of practice, of a duration and complexity that can be completed with the patient discharged during normal operational hours, and preceded by an evaluation the physician RECORDS — the patient’s condition, complicating morbidities, intrinsic risks and the invasiveness of what is planned. Separately, every physician must report any malpractice claim or lawsuit to the board within TEN DAYS of receipt or notification. Whether Arkansas separately registers a med spa as premises was not surveyed here. The cosmetology rules license the ESTABLISHMENT and price it: any person, firm or corporation conducting or operating a cosmetology establishment or mobile salon must obtain a current establishment license before operating, on an application to the Department of Health, with the proprietor responsible for compliance with the law and the State Board of Health’s rules; a new establishment or mobile salon is $100 one-time, renewal $50.00 annually, relocation $50.00, and renewal of a practitioner license $50.00 biennially, all nonrefundable. On compounded drugs the Board of Pharmacy’s compounding standard is direct: compounding a drug product that is commercially available, or that is essentially a copy of a commercially available FDA-approved product, is generally prohibited, with exceptions only for a slightly different product on a physician’s documented patient-specific medical need or where the product is not commercially available — unavailability documented before compounding — and pharmacies compounding or dispensing compounded products must comply with section 503A and the USP compounding chapters.

  • (a) Each office-based surgery shall be within the scope of practice of the physician. (b) Each office-based surgery shall be of a duration and complexity that can be undertaken safely and that can reasonably be expected to be completed, with the patient discharged, during normal operational hours. (c) Before the office-based surgery, the physician shall evaluate and record the condition of the patient, any specific morbidities that complicate operative and anesthesia management, the intrinsic risks involved, and the invasiveness of the planned office-based surgery, or any combination of these.

    17 CAR § 140-2904(a)-(c) (Office-based surgery)

  • (a)(1) Arkansas Code § 17-95-103 requires every physician licensed to practice medicine and surgery in the State of Arkansas to report to the Arkansas State Medical Board within ten (10) days after receipt or notification of any claim or filing of a lawsuit against him or her charging him or her with medical malpractice.

    17 CAR § 140-1701(a)(1) (Reporting generally)

  • All fees are nonrefundable upon submission: New establishment or mobile salon $100 one-time fee Renewal of an establishment or mobile salon $50.00 annually Relocation of establishment $50.00 one-time fee Renewal of a cosmetology, manicure, aesthetics, electrology, or instructor license $50.00 biennially

    17 CAR § 54-401(b) (Fees for cosmetology)

  • Any person, firm, or corporation conducting or operating a cosmetology establishment or mobile salon shall be required to obtain a current establishment license prior to operating said establishment. (2) The proprietor shall be responsible for compliance with the law and all rules promulgated by the State Board of Health. (3) Application. Any person, firm, or corporation desiring to open a cosmetology establishment or mobile salon shall submit an application to the Department of Health for approval.

    17 CAR § 54-202(a)(1)-(3) (Required licensure — establishment or mobile salon)

  • Arkansas generally prohibits compounding a copy of a commercially available drug, and semaglutide and tirzepatide are commercially available products. Compounding a drug product that is commercially available in the marketplace or that is essentially a copy of a commercially available Food and Drug Administration-approved drug product is generally prohibited. (2) However, in special circumstances a pharmacist may compound an appropriate quantity of a drug that is only slightly different than a Food and Drug Administration-approved drug that is commercially available: (A) Based on documentation provided by the prescribing physician of a patient-specific medical need (e.g., the physician requests an alternate product due to hypersensitivity to excipients or preservative in the Food and Drug Administration-approved product, or the physician requests an effective alternate dosage form); or (B) If the drug product is not commercially available.

    17 CAR § 160-2201(b)(1)-(2) (Standards for compounding and dispensing compounded products — copies of commercially available drugs)

  • The unavailability of such drug product must be documented prior to compounding. (B) The recommended methodology for documenting unavailability is to print the screen of wholesalers showing back-ordered, discontinued, or out-of-stock items, or maintaining a dated copy of the Food and Drug Administration shortage list that includes the specified drug, dosage form, and strength. (C) This or similar documentation must be available when requested by the Arkansas State Board of Pharmacy.

    17 CAR § 160-2201(b)(3) (documenting unavailability)

  • The purpose of this rule is to provide standards in the conduct, practices, and operations of a pharmacy preparing and dispensing compounded products. Pharmacies and pharmacists compounding, dispensing, or both compounding and dispensing compounded products shall comply with all requirements of Section 503A of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C.S. § 353a, other applicable federal, state, and local law or laws and rule or rules concerning pharmacy, as well as United States Pharmacopeia (USP) chapters relating to the compounding of medications including chapters below 1000.

    17 CAR § 160-2201(a), (d) (Standards for compounding — purpose; 503A and USP compliance)

  • Arkansas routes the report through the employer rather than the licensee, and a med spa is a required reporter. “Required reporter” reaches “any other entity that employs or contracts with healthcare professionals to provide healthcare services to individuals in the State of Arkansas”, and its chief executive officer or official agent “shall report to the appropriate licensing authority the following: (1) A final disciplinary action taken against a healthcare professional as a result of the diversion, misuse, or abuse of illicit drugs or controlled substances as defined by state and federal law by a healthcare professional; and (2) The voluntary resignation of any healthcare professional against whom a disciplinary action arising from the diversion, misuse, or abuse of illicit drugs or controlled substances … if a disciplinary action is pending.” The report “shall be submitted within seven (7) days of the final disciplinary action or voluntary resignation”.

    Ark. Code Ann. § 17-80-117(a)-(c) (Substance Abuse Reporting Act)

Advertising rules2 cited rules

The board separately treats grossly over-utilizing, ordering or performing tests or procedures on a patient as an ethical violation where that may result in harm.

Current as of Sep 20, 2026. Verify against the linked primary source and consult qualified counsel before acting — rules change and turn on your specific facts.

Who may perform it in Arkansas?

We hold Arkansas’s own written limits for chemical peel, injectable (neuromodulator, dermal filler), micropigmentation / permanent makeup, energy device (laser, IPL, RF, plasma, ultrasound), hair removal (laser / IPL) — read at source and cited. Check a licence against a procedure and see the rule it rests on.

Check scope in Arkansas →

Arkansas med spa compliance — FAQ

Where do Arkansas med spa and injectable regulations come from?
Arkansas med spas and injectors are governed by a mix of state and federal authorities — the Arkansas legislature, and the state's boards of nursing, medicine, and pharmacy, alongside federal bodies like the FDA and the Federal Register. MedSpaRadar monitors all of them for Arkansas and flags what changed in plain language.
Does the FDA's GLP-1 compounding guidance apply in Arkansas?
Yes — federal FDA actions on GLP-1 compounding (semaglutide, tirzepatide) apply nationwide, including in Arkansas. We track those federal changes alongside any Arkansas-specific rules so you see the full picture for your practice.
How do I keep up with Arkansas regulatory changes?
MedSpaRadar sends a free weekly Brief on what changed across Arkansas, the FDA, and the Federal Register. Members get the exact "what to do" for their states in one daily email. It's regulatory monitoring, not legal advice.

Get Arkansas changes as they publish

We scan the Arkansas legislature and licensing boards daily, plus the FDA and the Federal Register. Free weekly Brief — what changed, in plain language, with the source.

Free · unsubscribe in one click · we never sell your address

Related

← All states · MedSpaRadar is regulatory monitoring and reference: it summarizes public laws, regulations and agency actions and links each to its source. It is not legal, medical, or compliance advice, and using it creates no attorney-client relationship. A summary can lag its source or leave out detail, and monitoring itself can be interrupted — so an absence of alerts means nothing reached you, not that nothing happened. Read the cited source, check its effective date, and confirm any change to your operations or clinical practice with qualified health-law counsel and your medical director.